Stock
In this edition of StockCharts TV‘s The Final Bar, Dave answers viewer questions on using technical indicators on leveraged and inverse ETFs like SOXL and SOXS,...
Connect with us
Hi, what are you looking for?
The Independent Traders
- World News
How will DeSantis, Youngkin and other 2028 hopefuls stay relevant outside the Trump administration?
BRET BAIER: Inauguration Day spotlights America’s perpetual promise
Gunman shoots dead 2 Supreme Court judges in Iran’s capital before turning gun on himself, state media says
Biden appointed more federal judges than Trump did in his first term, new research shows
RNC chair on GOP’s mission going forward: ‘Make sure… Trump voters become Republican voters’
- Business
FDA officially authorizes Zyn nicotine pouches for sale following health review
Capital One outage drags into Friday afternoon, leaving some customers without deposit access
JPMorgan Chase posts record profit as the bank’s massive scale pays off
Target says its holiday sales were better than expected — but its profits weren’t
There’s been a ‘meaningful shift’ in CEO confidence since Trump’s election, says Goldman’s Solomon
- Stock
World News
NEWYou can now listen to Fox News articles! On January 20, 2025, at noon, Donald J. Trump will be sworn in as the 47th...
World News
During a busy week in the nation’s capital, far from the action, Florida Gov. Ron DeSantis had no trouble keeping his name in the...
Stock
Energy Replaces Technology At the end of this week, 1/17/2024, the Technology sector dropped out of the top 5 and will be replaced by...
Stock
When I look back at leading industry groups for the past day, week, month, 3-month, 6-month, and 1-year periods, only one industry group has...
Stock
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
Stock
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets....
Stock
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated...
Stock
Today on Fox Business Varney & Company, David Bahnsen (The Bahnsen Group) was asked if the current market reminded him of the Dot.com Bubble....
